Notebook

BASIC ADVOCATE: Maryland's Rita Colwell plans to advocate more basic science funding as the next NSF deputy director. On January 8, President Clinton announced his intent to nominate Rita R. Colwell as deputy director of the National Science Foundation. Colwell, currently the president of the University of Maryland Biotechnology Institute, says that if her nomination is confirmed, she will use the position to push for more research dollars for basic science. She remains unfazed by the limits t

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

BASIC ADVOCATE: Maryland's Rita Colwell plans to advocate more basic science funding as the next NSF deputy director. On January 8, President Clinton announced his intent to nominate Rita R. Colwell as deputy director of the National Science Foundation. Colwell, currently the president of the University of Maryland Biotechnology Institute, says that if her nomination is confirmed, she will use the position to push for more research dollars for basic science. She remains unfazed by the limits the balanced budget agreement places on available federal research funds. "Congress understands the value of science," she asserts. "I'm very optimistic." Colwell says she plans to draw on her experiences gained from serving on the National Science Board in 1983-89 to administer NSF programs. "I worked hard to learn as much as I could about the other areas of science," she recalls. "I'm extremely interested in furthering all the basic sciences and have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies